MAMMUCCI, PAOLO

MAMMUCCI, PAOLO  

Mostra records
Risultati 1 - 20 di 20 (tempo di esecuzione: 0.06 secondi).
Titolo Data di pubblicazione Autore(i) File
18F-FDG PET/CT in GIST treatment response evaluation beyond Imatinib 1-gen-2021 Altini, Corinna; Mammucci, Paolo; Pisani, Antonio Rosario; D'Alò, Claudia; Sardaro, Angela; Rubini, Dino; Ferrari, Cristina; Rubini, Giuseppe
[18F]FDG PET/CT in head and neck squamous cell carcinoma: a head-to-head between visual point-scales and the added value of multi-modality imaging 1-gen-2022 Ferrari, C.; Mammucci, P.; Lavelli, V.; Pisani, A. R.; Nappi, A. G.; Rubini, D.; Sardaro, A.; Rubini, G.
[18F]Fluciclovine PET/CT Improves the Clinical Management of Early Recurrence Prostate Cancer Patients 1-gen-2022 Nappi, A. G.; Ferrari, C.; Mammucci, P.; Rubini, D.; Lavelli, V.; Sardaro, A.; Pisani, A. R.; Rubini, G.
[18F]fluciclovine vs. [18F]fluorocholine Positron Emission Tomography/Computed Tomography: A Head-to-Head Comparison for Early Detection of Biochemical Recurrence in Prostate Cancer Patients 1-gen-2022 Ferrari, C.; Mammucci, P.; Lavelli, V.; Pisani, A. R.; Nappi, A. G.; Rubini, D.; Sardaro, A.; Rubini, G.
Diagnostic difficulties of antero-superior mediastinal masses with cardiac infiltration. Endovascular bioptic alternative approach 1-gen-2023 Maggialetti, Nicola; Gigante, Paola; Ciaccia, Michele; Mammucci, Paolo; Cianci, Valentina; Signorile, Antonio; Sasso, Sara; Dell'Atti, Cristian; Stabile Ianora, Amato Antonio
Diagnostic Value of Choline PET in the Preoperative Localization of Hyperfunctioning Parathyroid Gland(s): A Comprehensive Overview 1-gen-2021 Ferrari, Cristina; Santo, Giulia; Mammucci, Paolo; Pisani, Antonio Rosario; Sardaro, Angela; Rubini, Giuseppe
Early predictive response to multi-tyrosine kinase inhibitors in advanced refractory radioactive-iodine differentiated thyroid cancer: A new challenge for [18 f]fdg pet/ct 1-gen-2021 Ferrari, C.; Santo, G.; Ruta, R.; Lavelli, V.; Rubini, D.; Mammucci, P.; Sardaro, A.; Rubini, G.
Healthcare and economic impact of lung perfusion scintigraphy in patients affected by acute pulmonary embolism 1-gen-2021 Rubini, G.; Ferrari, C.; Mammucci, P.; Pisani, A. R.; Mincarone, P.; Leo, C. G.
Heterogeneous imaging features of Aspergillosis at 18F-FDG PET/CT 1-gen-2022 Altini, C.; Ruta, R.; Mammucci, P.; Rubini, D.; Ferrari, C.; Sardaro, A.; Pisani, A. R.
Imaging in breast cancer follow-up: preliminary investigation on clinical practice adherence to the guidelines 1-gen-2021 Sardaro, A.; Altini, C.; Frugis, M. T.; Ferrari, C.; Mammucci, P.; Rubini, D.; Maggialetti, N.; Rubini, G.
Intracranial Solitary Fibrous Tumor: A “New” Challenge for PET Radiopharmaceuticals 1-gen-2022 Sardaro, A.; Mammucci, P.; Pisani, A. R.; Rubini, D.; Nappi, A. G.; Bardoscia, L.; Rubini, G.
Lesion-to-Liver SUVmax Ratio to Improve the Prognostic Value of the End of Treatment PET/CT in Diffuse Large B-Cell Lymphoma 1-gen-2022 Ferrari, C.; Pisani, A. R.; Masi, T.; Santo, G.; Mammucci, P.; Rubini, D.; Sardaro, A.; Rubini, G.
Lympho-SPECT/CT as a Key Tool in the Management of a Patient with Chylous Ascites 1-gen-2023 Iuele, F.; Rubini, D.; Altini, C.; Mammucci, P.; Pisani, A. R.
Prognostic Value of the BIO-Ra Score in Metastatic Castration-Resistant Prostate Cancer Patients Treated with Radium-223 after the European Medicines Agency Restricted Use: Secondary Investigations of the Multicentric BIO-Ra Study 1-gen-2022 Bauckneht, M.; Rebuzzi, S. E.; Ponzano, M.; Borea, R.; Signori, A.; Frantellizzi, V.; Rizzini, E. L.; Mascia, M.; Lavelli, V.; Miceli, A.; De Feo, M. S.; Pisani, A. R.; Nuvoli, S.; Tripoli, V.; Morganti, A. G.; Mammucci, P.; Caponnetto, S.; Mantica, G.; Di Nicola, A. D.; Villano, C.; Cindolo, L.; Morbelli, S.; Sambuceti, G.; Fanti, S.; Costa, R. P.; Spanu, A.; Rubini, G.; Monari, F.; De Vincentis, G.; Fornarini, G.
Sixteen-Year Follow-Up in a Cavernous Sinus Hemangiopericytoma: Improved Outcomes over Radiotherapy Advances 1-gen-2022 Detti, B.; Bardoscia, L.; Pisani, A. R.; Cozzi, S.; Roghi, M.; Mammucci, P.; Sardaro, A.
The day after mass covid-19 vaccination: Higher hypermetabolic lymphadenopathy detection on pet/ct and impact on oncologic patients management 1-gen-2021 Ferrari, C.; Nappi, A. G.; Santo, G.; Mammucci, P.; Rubini, D.; Tucci, M.; Pisani, A. R.
The day after mass COVID-19 vaccination: incidence of vaccine-related lymphadenopathy PET and impact on oncologic patients management 1-gen-2021 Ferrari, Cristina; Nappi, ANNA GIULIA; Santo, Giulia; Mammucci, Paolo; Rubini, Dino; Tucci, Marco; Rosario Pisani, Antonio
The prognostic power of inflammatory indices and clinical factors in metastatic castration-resistant prostate cancer patients treated with radium-223 (BIO-Ra study) 1-gen-2022 Bauckneht, M.; Rebuzzi, S. E.; Signori, A.; Frantellizzi, V.; Murianni, V.; Lodi Rizzini, E.; Mascia, M.; Lavelli, V.; Donegani, M. I.; Ponzano, M.; Gaudiano, A.; Stazza, M. L.; Licari, M.; Cavallini, L.; Laghi, V.; Cindolo, L.; Maggi, M.; Sciarra, A.; Mammucci, P.; Sambuceti, G.; Costa, R. P.; Spanu, A.; Rubini, G.; Monari, F.; De Vincentis, G.; Fornarini, G.
The significant role of multimodality imaging with 18Fluorocholine PET/CT in relapsed intracranial hemangiopericytoma 1-gen-2021 Sardaro, A.; Ferrari, C.; Mammucci, P.; Piscitelli, D.; Rubini, D.; Maggialetti, N.
Volumetric Modulated Arc Radiotherapy Efficacy After Double Recurrences of Cardiac Sarcoma 1-gen-2024 Rosario Pisani, Antonio; Sardaro, Angela; Maggialetti, Nicola; Altini, Corinna; Rubini, Dino; Mammucci, Paolo; Rubini, Giuseppe